Johan Vansteenkiste Selected Research

Johan Vansteenkiste Research Topics

Disease

78	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2023 - 07/2002
55	Neoplasms (Cancer) 01/2022 - 08/2002
22	Lung Neoplasms (Lung Cancer) 01/2023 - 07/2002
17	Disease Progression 01/2021 - 10/2005
16	Anemia 05/2023 - 08/2002
6	Neutropenia 05/2023 - 05/2007
6	Pneumonia (Pneumonitis) 01/2023 - 01/2009
5	Febrile Neutropenia 05/2023 - 05/2007
5	Neoplasm Metastasis (Metastasis) 12/2019 - 11/2010
5	Exanthema (Rash) 04/2015 - 04/2007
4	Adenocarcinoma 05/2023 - 07/2008
4	Diarrhea 04/2015 - 04/2007
4	Melanoma (Melanoma, Malignant) 03/2014 - 07/2011
3	Thrombocytopenia (Thrombopenia) 05/2023 - 05/2007
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018 - 03/2006
3	Fatigue 01/2018 - 08/2002
3	Adenocarcinoma of Lung 08/2015 - 02/2011
2	Alopecia (Baldness) 05/2023 - 07/2008
2	Nausea 05/2023 - 07/2008
2	Large Cell Carcinoma 05/2023 - 07/2008
2	Inflammation (Inflammations) 01/2022 - 11/2018
2	Breast Neoplasms (Breast Cancer) 11/2021 - 12/2018
2	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 11/2018
2	Dehydration (Water Stress) 11/2018 - 03/2014
2	Infections 11/2018 - 05/2007
2	Vomiting 01/2018 - 03/2014
2	Hemorrhage 02/2011 - 05/2007
2	Hypoxia (Hypoxemia) 07/2009 - 06/2007
1	Carcinoid Tumor (Carcinoid) 05/2022
1	Necrosis 01/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Renal Insufficiency (Renal Failure) 01/2020
1	Acute Tubulointerstitial Nephritis 01/2020

Drug/Important Bio-Agent (IBA)

14	Cisplatin (Platino)FDA LinkGeneric 05/2023 - 07/2002
13	Darbepoetin alfa (Aranesp)FDA Link 01/2016 - 08/2002
11	Pemetrexed (MTA)FDA Link 05/2023 - 05/2007
10	Tyrosine Kinase InhibitorsIBA 01/2023 - 06/2003
9	Hemoglobins (Hemoglobin)IBA 01/2016 - 08/2002
8	AntigensIBA 01/2019 - 07/2011
7	Gemcitabine FDA Link 05/2023 - 05/2003
7	osimertinibIBA 01/2023 - 08/2018
7	PlatinumIBA 11/2021 - 08/2007
7	Docetaxel (Taxotere)FDA Link 01/2021 - 04/2008
7	HematinicsIBA 04/2013 - 06/2009
6	ErbB Receptors (EGF Receptor)IBA 01/2023 - 06/2003
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 07/2009
4	Immune Checkpoint InhibitorsIBA 01/2023 - 10/2015
4	Gefitinib (Iressa)FDA Link 01/2023 - 06/2003
4	LigandsIBA 05/2022 - 01/2014
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 01/2014
4	VaccinesIBA 03/2014 - 07/2011
3	durvalumabIBA 01/2020 - 01/2018
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2019 - 10/2002
3	Proteins (Proteins, Gene)FDA Link 12/2018 - 07/2011
3	Monoclonal AntibodiesIBA 01/2017 - 01/2014
3	ceritinibIBA 04/2016 - 03/2014
3	Glucose (Dextrose)FDA LinkGeneric 04/2016 - 06/2007
3	belagenpumatucel LIBA 03/2014 - 07/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 08/2018
2	Programmed Cell Death 1 ReceptorIBA 01/2022 - 01/2014
2	avelumabIBA 01/2021 - 11/2018
2	pyrimidineIBA 05/2019 - 01/2017
2	AntibodiesIBA 11/2018 - 01/2014
2	Anaplastic Lymphoma KinaseIBA 01/2018 - 03/2014
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018 - 01/2016
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018 - 02/2015
2	Transaminases (Aminotransferases)IBA 01/2018 - 03/2014
2	atezolizumabIBA 01/2017 - 04/2016
2	AZD 6244IBA 01/2017 - 01/2013
2	B7-H1 AntigenIBA 01/2017 - 04/2016
2	CrizotinibIBA 04/2016 - 03/2014
2	Etoposide (VP 16)FDA LinkGeneric 03/2016 - 01/2009
2	Epidermal Growth Factor (EGF)IBA 01/2016 - 07/2011
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2015 - 04/2007
2	L-BLP25IBA 06/2014 - 01/2014
2	taxaneIBA 08/2008 - 08/2007
2	Vindesine (Vindesin)IBA 05/2003 - 07/2002
1	Somatostatin Receptors (Somatostatin Receptor)IBA 05/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor Receptors (GM-CSF Receptor)IBA 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022
1	Interleukin-23 (Interleukin 23)IBA 01/2022
1	Transfer RNA (tRNA)IBA 01/2022
1	Small Cytoplasmic RNAIBA 01/2020
1	capmatinibIBA 01/2020
1	CollagenIBA 01/2020

Therapy/Procedure

41	Drug Therapy (Chemotherapy) 05/2023 - 07/2002
36	Therapeutics 01/2020 - 08/2002
15	Immunotherapy 01/2023 - 07/2013
9	Radiotherapy 12/2016 - 07/2002
6	Induction Chemotherapy 01/2014 - 11/2005
5	Chemoradiotherapy 01/2023 - 01/2009
4	Adjuvant Chemotherapy 01/2016 - 01/2004
2	Aftercare (After-Treatment) 12/2018 - 11/2018
2	Immunomodulation 10/2015 - 01/2014
2	Erythrocyte Transfusion 04/2013 - 11/2012
2	Thoracotomy 11/2010 - 01/2009
1	Neoadjuvant Therapy 01/2020